GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » EV-to-FCF

Icecure Medical (Icecure Medical) EV-to-FCF : -3.31 (As of May. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Icecure Medical's Enterprise Value is $43.04 Mil. Icecure Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-13.00 Mil. Therefore, Icecure Medical's EV-to-FCF for today is -3.31.

The historical rank and industry rank for Icecure Medical's EV-to-FCF or its related term are showing as below:

ICCM' s EV-to-FCF Range Over the Past 10 Years
Min: -138.85   Med: -3.41   Max: -1.08
Current: -3.31

During the past 11 years, the highest EV-to-FCF of Icecure Medical was -1.08. The lowest was -138.85. And the median was -3.41.

ICCM's EV-to-FCF is ranked worse than
100% of 362 companies
in the Medical Devices & Instruments industry
Industry Median: 27.855 vs ICCM: -3.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-10), Icecure Medical's stock price is $1.16. Icecure Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.320. Therefore, Icecure Medical's PE Ratio for today is At Loss.


Icecure Medical EV-to-FCF Historical Data

The historical data trend for Icecure Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical EV-to-FCF Chart

Icecure Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.38 -9.53 -6.43 -3.14 -2.96

Icecure Medical Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.14 -3.13 -3.43 -1.48 -2.96

Competitive Comparison of Icecure Medical's EV-to-FCF

For the Medical Devices subindustry, Icecure Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icecure Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Icecure Medical's EV-to-FCF falls into.



Icecure Medical EV-to-FCF Calculation

Icecure Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=43.041/-13.001
=-3.31

Icecure Medical's current Enterprise Value is $43.04 Mil.
Icecure Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icecure Medical  (NAS:ICCM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Icecure Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.16/-0.320
=At Loss

Icecure Medical's share price for today is $1.16.
Icecure Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.320.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Icecure Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Icecure Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Icecure Medical (Icecure Medical) Business Description

Traded in Other Exchanges
N/A
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical (Icecure Medical) Headlines

From GuruFocus